For evaluation-stage readers, BPC-157 vs TB-500: how the two peptides compare and GHK-Cu are the most common next stops alongside the dosing protocol
Consider injection-site infection, allergy, hepatic injury, renal dysfunction, glucose disturbance and consequences of activation of the growth hormone pathway
GHK-Cu is a copper-binding peptide complex studied for its relevance to copper-peptide signaling, extracellular matrix research models, collagen-associated pathways, dermatological research contexts, tissue-response environments, and hair-follicle research models
Prevention: cycle 5 days on, 2 days off for topical use
Each lot is a synthetic pentadecapeptide corresponding to the 15-residue sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (GEPPPGKPADDAGLV), assembled by solid-phase peptide synthesis and purified to not less than 98% by reversed-phase HPLC, with lot-specific results documented on the Certificate of Analysis available on request
It has not been approved by the FDA to treat any condition, and bodily introduction is not permitted